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Cerebral venous thrombosis (CVT) is one of the rare stroke types which results in the formation 
of blood clots in the venous sinuses that responsible for brain drainage. Surface and deep vein 
drain into the dural sinuses and these sinuses are also evacuated to jugular veins. In the CVT of the 
brain, blood clots can be produced in the veins or the sinuses. Venous thrombosis can cause venous 
infarction as are sult of brain tissue damage due to compression scant blood flow [1]. Although 
intravenous CVT known as a rare disease and includes less than 1% of brain stroke, in recent years 
its recognition has increased with the use of MRI and exact identification of its clinical symptoms 
[1-3]. CVT was first reported in 1825 and its exact incidence rate is unknown but can affect all age 
groups from 6 days to 77 years. The average age is 33 years and the prevalence is higher in women 
(Khosravi).
The risks of CVT include systemic conditions such as pregnancy, hyperviscoziteh syndromes, 
Behcet, coagulopathy such as protein C resistance, factor V mutation in Leiden, collagen vascular 
disease and antiphospholipid antibodies .Involvement in young women is important because it can 
be occur due to the use of contraceptive pills [4].
Oral contraceptive Pill (OCP) is a major risk factor for CVT and routinely should be considered. 
In many studies, OCP is the most common underlying cause in women. Due to the wide range 
of clinical Symptoms diagnosis of disease may be delayed and mistaken with other pathological 
conditions. This range of resistant headaches may be different from severe syndromes of intracranial 
pressure, nerve defects focal and Kuma and so they should be distinguished in differential diagnosis 
of all secondary headaches. In studies, mutual headache was the most common symptom with no 
specific pattern. Before confirming the diagnosis, one third of patients experience focal or generalized 
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Abstract
Background and objective: In Cerebral venous thrombosis (CVT), blood clots create in the veins and 
sinuses. Detection of disease due to the wide spectrum of clinical symptoms may be delayed, the importance 
of timely diagnosis of this disease is that with early treatment, death can be avoided and serious and lifelong 
complications can be prevented in many patients. Also, recognizing the underlying causes and other factors that 
contribute to the onset of the disease can prevent the disease. 
Methods: This cross-sectional descriptive study has been done on 28 patients diagnosed with cerebral 
venous sinus thrombosis during years 2012 to 2017 that hospitalized in Ardabil city hospital. Demographic 
data of patients and information about laboratory tests and clinical and Para-clinical findings were entered in a 
checklist and then analyzed by statistical methods in SPSS version 19. 
Results: The mean age of the patients was 36.6 ± 8.7 years and most of them were in age group less 
than 30. Of all patients, 53.6% were female. The most prevalent symptoms and signs among patients was 
headache. Upper sagittal sinus with 50% was the most prevalent involved vein. 53.4% of women were taking 
oral contraceptive pills (OCP) and 46.2% of male patients had smoking and drug addiction. Thrombotic occlusion 
often affected the sagittal and then transverse sinuses. 10 cases (35.7%) had findings based on ischemia and 4 
(14.3%) had intracranial hemorrhage.
Conclusion: The results showed that the high incidence of CVT in females was more than males which 
can be the sign for relation between CVT with factors such as OCP use and pregnancy. Also regarding to the 
vomiting and dizziness as the most common clinical symptoms in patients so it can be a means of distinguishing 
headaches caused by the disease with other common headaches and help in diagnosis.
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seizures that in some cases it can lead to death [1,4]. Considering 
the importance and necessity of timely diagnosis of this disease as 
well as low number of studies in this field in the province and the 
country level, the aim of this study was to investigate the frequency 
demographic, characteristics and clinical findings of CVT in patients 
referred to Ardabil city hospital.
Material and Methods
This is a descriptive cross-sectional study that was done on 28 
hospitalized patients with CVT who were hospitalized in Ardabil city 
hospital from Sep 2012 to Sep 2017. The primary diagnosis of the 
disease was based on a clinical presentation and performed by MRI or 
CT scan and final confirmation by magnetic resonance venography 
(MRV) and radiology report. History and primary symptoms of 
patients were registered through examinations by physicians in the 
emergency department. Brain MRI and MRV imaging was performed 
for all patients and radiology report was done for all MRV. The final 
site of the CVT written in the file of patients based on the diagnosis 
of a doctor and radiology report. The method of sampling was census 
and all of patients entered in the study. Demographic data including 
age, sex, season of the incidence of CVT, effective risk factors and 
laboratory tests such as CBC - PT - PTT - INR, Serum Level of Protein 
S and serum level of protein C were collected for all patients during 
hospitalization.
Statistical analysis
 Statistical analysis was done using the SPSS 19.0 program 
(Statistical Package for Social Sciences; SPSS Inc., Chicago, IL, USA) 
for Windows 8 by using descriptive and analytical statistical methods. 
The significant level was considered to be less than 5%. 
Results
The average age of the patients was 36.6 ± 8.7 years (range: 
16-60) and most of the patients were in the age group less than 30 
years. The average age of women was 35.2 ± 7.6 and the men were 
39 ± 9.2 years. Of all patients, 15 (53.6%) were female and the rest 
of them were male. The most common clinical symptoms were 
headache (96.4%) (Figure 1). The upper sagittal sinus with 50% was 
the most common venous involvement in patients (Figure 2). 53.4% 
of women with CVT had OCP use and 46.2% of male patients with 
CVT had smoking or opium use. In summary OCP use with 46.2% 
and smoking and opium use and idiopathic each with 21.4% were 
the major risk factor for CVT (Table 1). Of all patients, 10 (35.7%) 
had parenchymal infarction or lesion and 4 (14.3%) had intracranial 
hemorrhage in the brain imaging [5-11].
Discussion
In this study of all patients, 15 (54%) were female and 13 (46%) 
were male. In other studies in Saudi Arabia, Kuwait, Mashhad, Tehran 
and Isfahan the number of women was more. In previous studies, the 
prevalence of the disease in women compare to the total population 
is usually above 70% that in the present study the prevalence rate in 
female was 54% and in men was 46% that can be due to causes such 
96.4
60.7








































Figure 2: Frequency of involved veins in CVT patients.
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as trauma, smoking and opium abuse which was more prevalent in 
men [10,12-15]. The average age of patients was 36.6 years old in the 
range of 16-61 which compared to other studies; the age range of 
patients was similar. This finding confirm that the people in the age 
range of 30 to 40years was at risk which was the effective people in 
the country [12-15,10]. Of the complaints and clinical symptoms, the 
most common clinical finding in patients was headache with 96.4%. 
In a study by Nikkaha et al., in Mashhad, 100% of patients, Lotfi et al, 
study in Tehran 80%, a study by Sadat Nia et al., in Isfahan 94% of 
patients, Kajtazi et al., study in Saudi 77% and Vembu et al., in Kuwait 
93% of patients, have complained of a headache [10,12-15].
There was papilledema in32% of patients in the current study and 
an obvious difference was seen in its prevalence with other studies in 
the country which had occurrence between 50-70% [13,14].
Among other clinical symptoms, the prevalence of seizures 
was almost in line with other studies and there was no significant 
difference [10,12-15]. In the case of etiology and etiologic factors of 
the disease, the most prevalent cause of disease in women was oral 
contraceptive pills with 53.4% and in men was smoking and drug 
abuse with 46.2%.The most common etiologic predisposing factor to 
the disease in the current study was oral contraceptive use in women 
with 53.4% which was in line with other studies which conducted 
in the country and in Saudi Arabia and Kuwait [10,12-15]. In the 
study of Lotfi et al., in Tehran, in 26% of cases, the underlying cause 
of infectious was reported. This finding could indicate a reduction 
in infectious causes and a reduction in the incidence of infectious 
diseases due to the widespread use of antibiotics and an increase in 
personal hygiene or justifying with the living conditions of people in 
each are [14]. In the present study, the upper sagittal sinus with 50% 
was in the high priority in terms of sinus thrombosis location. In some 
patients, there has been a combination of multiple sinus and venous 
involvement. In this study similar to other studies, the most common 
location of involvement were upper sagittal sinus and then transverse 
sinus [10,12-15]. CVT was seen in only 3% of cases and in compare to 
other studies was low that can be due to presence of genetic disorders 
predisposing conditions in patients. So, we can said that perhaps the 
differences in the genetics of different races has been the cause of this 
result [12-15,10]. The prevalence of headache were 70%, 86.4%,100% 
and 84.6% in the studies by Foroghi poor et al, 22 Khomand et al., 
Nikkhah et al., and Amirifard et al, respectively which was lower than 
other study results in most of them [16-19].
In the present study, OCP, smoking and opium use and Idiopathic 
were the major risk factors for CVT which wasn’t similar to Amirifard 
and et al, study that reported infection, pregnancy, postpartum period 
and dehydration as the major risk factors for CVT [19]. 
Conclusion
In the present study the results of previous studies regarding 
the more incidence of CVT in female were confirmed. Also, most 
of patients were in the age group less than 40 years. Headache and 
dizziness were the main clinical symptoms in patients. The thrombotic 
obstruction involved most of the sagittal and transverse sinuses. OCP 
use in women and smoking in men were identified as the main risk 
factor for CVT incidence. Considering the low number of patients in 
this study and the difference in risk factors and clinical symptoms. 
We suggest that a study be conducted with longer duration in this 
topic on more samples in future. Also, doing case-control studies on 
relation between OCP and CVT by determining its type, duration and 
rate of using drugs can provide useful information on CVT common 
cause in future. 
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n % n % n %
OCP use 0 0 8 53.3 8 28.6
Pregnancy & Postpartum period 0 0 2 13.3 2 7.1
Lower protein S 1 7.7 1 6.7 2 7.1
Smoking and opium abuse 6 46.2 0 0 6 21.4
Using steroid drugs 1 7.7 2 13.3 3 10.7
Lupus 0 0 1 6.7 1 3.6
Rheumatoid Arthritis 0 0 1 6.7 1 3.6
Polycythemia 1 7.7 0 0 1 3.6
Thrombosis 1 7.7 0 0 1 3.6
Malignancy 2 15.4 0 0 2 7.1
Infection 2 15.4 0 0 2 7.1
Heart disease 0 0 1 6.7 1 3.6
Idiopathic 2 15.4 4 26.7 6 21.4
Table 1: The frequency of risk factors for CVT in patients by sex.
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